Nexvet Biopharma plc — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2016)

-$19.4M

Total Assets (FY2016)

$40.3M

Total Equity (FY2016)

$35.1M

Cash Flows from Operating Activities (FY2016)

-$14.8M

Source: Nexvet Biopharma plc 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.